HUMAN IMMUNODEFICIENCY VIRUS
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One shot, two problems: monthly injection aims to treat HIV and opioid addiction together
Disease control TerminatedThis study aimed to test a combined monthly injection treatment for people living with both HIV and opioid addiction. The goal was to see if giving both medications in one visit would make treatment easier and improve adherence. The trial was withdrawn before any participants wer…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new combo aiming for HIV 'Drug Holiday'
Disease control OngoingThis early-stage study is testing a new combination treatment for HIV. It involves two lab-made antibodies and an immune system booster. The goal is to see if this combo is safe and can control the virus well enough for participants to safely stop their daily antiviral pills for …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New program aims to break down barriers between HIV and mental health care
Disease control OngoingThis study is testing a new clinic program called CHIMES, designed to better connect HIV care with mental health services. It focuses on young Black gay and bisexual men living with HIV in Atlanta, a group that often faces barriers to getting mental health support. The goal is to…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New strategy trains nurses to tackle silent killer in HIV clinics
Disease control OngoingThis study is testing a new coaching program to help nurses better manage high blood pressure in patients who are also living with HIV. It involves 830 adults with uncontrolled blood pressure across 30 primary health clinics in Nigeria. The goal is to see if providing nurses with…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Phone vs. In-Person: can better support keep HIV-Positive teens in care?
Disease control OngoingThis study is testing two different support programs to help teenagers with HIV in South Africa successfully move from pediatric to adult healthcare. It compares in-person support groups to a mobile phone-based program, aiming to see which helps teens stay on their medication and…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
AI steps in to help keep HIV patients on track
Disease control ENROLLING_BY_INVITATIONThis study is testing whether computer algorithms can help HIV clinics in Kenya improve patient care. The algorithms will try to predict which patients are most likely to miss appointments or have their treatment stop working. Clinics that use these predictions will be compared t…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: Brown University • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
New hope to stop cervical cancer in High-Risk women
Disease control OngoingThis study is testing whether a vaginal insert (artesunate) can help clear HPV infection and prevent cervical precancer from returning in women living with HIV. It aims to improve the success of standard thermal ablation treatment, which often fails in this high-risk group. The t…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Feb 24, 2026 14:07 UTC
-
Home delivery vs. clinics: new study tests easier way to get HIV prevention pills
Prevention OngoingThis study is testing whether delivering HIV prevention medication (PrEP) directly to people in their communities is more effective than requiring them to visit clinics. It involves 2,500 young women and men in South Africa who are at high risk for HIV. The goal is to see if this…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Mar 19, 2026 14:56 UTC